The Effect of Chromium Glycinate on the Blood Glucose Control and Blood Lipids of Normal and Diabetic Patients

Abstract

The effect of chromium glycinate 200 μg was investigated for its effect on blood control and serum lipids in four groups were divided into normal subjects (n = 30), hyperglycemic (n = 28), no-insulin dependent diabetics (n = 20) and insulin-dependent diabetics (n = 20). The level of glucose and lipids profile in serum were analyzed before chromium glycinate supplements and periodically each two weeks throughout this study after chromium glycinate 200 μg supplements was taken for a period of four months. A significant improvements in the various parameters occurred in all groups of the study. The hyperglycemic group showed higher benefits in blood glucose control, lowered serum lipids and a decreased risk of coronary heart disease than other groups of no-insulin dependent diabetics and insulin-dependent diabetics.